Kyverna Therapeutics Inc.
3.29
-0.04 (-1.20%)
At close: Jan 15, 2025, 3:59 PM
3.29
-0.03%
After-hours Jan 15, 2025, 04:00 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21
PE Ratio -334.77 -26.79 -29.38
PS Ratio n/a 110.19 136.87
PB Ratio 410.94 -10.46 -16.74
P/FCF Ratio -381.07 -20.99 -33.02
P/OCF Ratio -385.59 -21.44 -34.94
OCF/S Ratio n/a -5.14 -3.92
Debt / Equity Ratio 0.18 -0.14 -0.12
Quick Ratio 3.05 4.45 4.84
Current Ratio 3.05 4.45 4.84
Asset Turnover n/a 0.10 0.07
Interest Coverage -333.72 -452.06 -8.78K
Return on Equity (ROE) -1.23 0.39 0.57
Return on Assets (ROA) -0.8 -0.43 -0.31
Return on Capital (ROIC) -1.13 -0.53 -0.38
Dividend Yield n/a n/a n/a
Payout Ratio n/a n/a n/a
Gross Profit Margin n/a 85.04% 89.64%
Net Profit Margin n/a -411.29% -465.88%
Pretax Profit Margin n/a -411.29% -465.88%
Operating Profit Margin n/a -418.28% -465.81%
FCF Margin n/a -525% -414.5%
EBITDA Margin n/a -395.4% -455.46%